Expression and Function of Renal and Hepatic Organic Anion Transporters in Extrahepatic Cholestasis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2012 Dec 1

PMID 23197884

Citations 13

Authors

Anabel Brandoni

Maria Herminia Hazelhoff

Romina Paula Bulacio

Adriana Monica Torres

Affiliations

Soon will be listed here.

Abstract

Obstructive jaundice occurs in patients suffering from cholelithiasis and from neoplasms affecting the pancreas and the common bile duct. The absorption, distribution and elimination of drugs are impaired during this pathology. Prolonged cholestasis may alter both liver and kidney function. Lactam antibiotics, diuretics, non-steroidal anti-inflammatory drugs, several antiviral drugs as well as endogenous compounds are classified as organic anions. The hepatic and renal organic anion transport pathways play a key role in the pharmacokinetics of these compounds. It has been demonstrated that acute extrahepatic cholestasis is associated with increased renal elimination of organic anions. The present work describes the molecular mechanisms involved in the regulation of the expression and function of the renal and hepatic organic anion transporters in extrahepatic cholestasis, such as multidrug resistance-associated protein 2, organic anion transporting polypeptide 1, organic anion transporter 3, bilitranslocase, bromosulfophthalein/bilirubin binding protein, organic anion transporter 1 and sodium dependent bile salt transporter. The modulation in the expression of renal organic anion transporters constitutes a compensatory mechanism to overcome the hepatic dysfunction in the elimination of organic anions.

Citing Articles

Pathophysiology of sepsis-induced cholestasis: A review.

Ghenu M, Dragos D, Manea M, Ionescu D, Negreanu L JGH Open. 2022; 6(6):378-387.

PMID: 35774351 PMC: 9218521. DOI: 10.1002/jgh3.12771.

Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease.

Nigam A, Ojha A, Li J, Shi D, Bhatnagar V, Nigam K Pharmaceutics. 2021; 13(10).

PMID: 34684013 PMC: 8538396. DOI: 10.3390/pharmaceutics13101720.

Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition.

Saib S, Delavenne X Pharmaceutics. 2021; 13(10).

PMID: 34683838 PMC: 8539483. DOI: 10.3390/pharmaceutics13101544.

Kolaviron Diminishes Diclofenac-Induced Liver and Kidney Toxicity in Wistar Rats Via Suppressing Inflammatory Events, Upregulating Antioxidant Defenses, and Improving Hematological Indices.

Alabi Q, Akomolafe R Dose Response. 2020; 18(1):1559325819899256.

PMID: 32165871 PMC: 7054740. DOI: 10.1177/1559325819899256.

The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Nigam S Annu Rev Pharmacol Toxicol. 2018; 58:663-687.

PMID: 29309257 PMC: 6225997. DOI: 10.1146/annurev-pharmtox-010617-052713.

References

Denk G, Soroka C, Takeyama Y, Chen W, Schuetz J, Boyer J . Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol. 2004; 40(4):585-91. DOI: 10.1016/j.jhep.2003.12.001. View

Sweet D . Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol Appl Pharmacol. 2005; 204(3):198-215. DOI: 10.1016/j.taap.2004.10.016. View

Burckhardt G, Burckhardt B . In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. Handb Exp Pharmacol. 2010; (201):29-104. DOI: 10.1007/978-3-642-14541-4_2. View

Dietrich C, Geier A, Salein N, Lammert F, Roeb E, Oude Elferink R . Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology. 2004; 126(4):1044-53. DOI: 10.1053/j.gastro.2003.12.046. View

Nies A, Keppler D . The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 2006; 453(5):643-59. DOI: 10.1007/s00424-006-0109-y. View

Cheng X, Maher J, Dieter M, Klaassen C . Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab Dispos. 2005; 33(9):1276-82. DOI: 10.1124/dmd.105.003988. View

Torres A, MacLaughlin M, Quaglia N, Stremmel W . Role of BSP/bilirubin binding protein on p-aminohippurate transport in rat kidney. Mol Cell Biochem. 2003; 245(1-2):149-56. DOI: 10.1023/a:1022833713727. View

Pei Q, Kobayashi Y, Tanaka Y, Taguchi Y, Higuchi K, Kaito M . Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatol Res. 2002; 22(1):58-64. DOI: 10.1016/s1386-6346(01)00110-3. View

Wu W, Dnyanmote A, Nigam S . Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol. 2011; 79(5):795-805. PMC: 3082935. DOI: 10.1124/mol.110.070607. View

10.

Hagenbuch B, Meier P . The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta. 2003; 1609(1):1-18. DOI: 10.1016/s0005-2736(02)00633-8. View

11.

Ahn S, Nigam S . Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol. 2009; 76(3):481-90. PMC: 2730381. DOI: 10.1124/mol.109.056564. View

12.

Srimaroeng C, Perry J, Pritchard J . Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica. 2008; 38(7-8):889-935. PMC: 2644066. DOI: 10.1080/00498250801927435. View

13.

Donner M, Keppler D . Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology. 2001; 34(2):351-9. DOI: 10.1053/jhep.2001.26213. View

14.

Planchamp C, Hadengue A, Stieger B, Bourquin J, Vonlaufen A, Frossard J . Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes. Mol Pharmacol. 2007; 71(4):1089-97. DOI: 10.1124/mol.106.030759. View

15.

Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K . Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol. 1999; 10(3):464-71. DOI: 10.1681/ASN.V103464. View

16.

Tiribelli C, Lunazzi G, Luciani M, Panfili E, Gazzin B, Liut G . Isolation of a sulfobromophthalein-binding protein from hepatocyte plasma membrane. Biochim Biophys Acta. 1978; 532(1):105-12. DOI: 10.1016/0005-2795(78)90453-1. View

17.

Geier A, Dietrich C, Trauner M, Gartung C . Extrahepatic cholestasis downregulates Oatp1 by TNF-alpha signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver. Liver Int. 2007; 27(8):1056-65. DOI: 10.1111/j.1478-3231.2007.01523.x. View

18.

Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E . Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab. 2009; 10(4):369-94. DOI: 10.2174/138920009788498950. View

19.

Brandoni A, Quaglia N, Torres A . Compensation increase in organic anion excretion in rats with acute biliary obstruction: role of the renal organic anion transporter 1. Pharmacology. 2003; 68(2):57-63. DOI: 10.1159/000069529. View

20.

Cha S, Sekine T, Fukushima J, Kanai Y, Kobayashi Y, Goya T . Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001; 59(5):1277-86. DOI: 10.1124/mol.59.5.1277. View